Hepatocellular carcinoma and type 2 diabetes mellitus: two cases highlighting changes in tumor glycogen content

Abstract

This article reports two patients with hepatocellular carcinoma (HCC) and type 2 diabetes mellitus (T2DM), who showed marked changes in hepatocellular glycogen content. Periodic acid-Schiff (PAS)-positive and diastase-PAS-negative (glycogen-storing) hepatocytes were detected in both background liver parenchyma and in HCC tissues. In HCC tissues, the number of glycogen-storing cells resembling hepatocytes was considerably reduced and unevenly distributed as compared with hepatocytes in background liver. To be known, changes in hepatocellular glycogen content in T2DM patients have not been previously described. It is hypothesized that the reduction in glycogen content in both patients was likely associated with the emergence of Warburg type of glycolysis.

Keywords

Glycogen / hepatocellular carcinoma / hexokinase II / steatohepatitis / type 2 diabetes mellitus

References

[1] El-Serag HB.Hepatocellular carcinoma: epidemiology and molecular carcinogenesis..Gastroenterology2007;132:2557-76

[2] Donato F,Gelatti U,Boffettta P,Decarli A,Ribero ML,Porru S.Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infection in men and women..Am J Epidemiol2002;155:323-31

[3] Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010;51:1820-2.

[4] Yang WS,Bray F,Gao J,Xiang YB.The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies..PLoS One2011;6:e27326 PMCID:PMC3244388

[5] Evans RW,Pemberton HS.Glycogen storage in the liver in diabetes mellitus..J Clin Pathol1955;8:110-3 PMCID:PMC1023765

[6] Stone BG.Diabetes mellitus and the liver..Semin Liver Dis1985;5:8-28

[7] Bannasch P.The cytoplasm of hepatocytes during carcinogenesis. Electron and light microscopical investigations of the nitrosomorpholine-intoxicated rat liver..Rec Res Cancer Res1968;19:1-100

[8] Dombrowski F,Pfeifer U.Hepatocellular neoplasms induced by low-number pancreatic islet transplants in streptozotocin diabetic rats..Am J Pathol1997;150:1071-87 PMCID:PMC1857898

[9] Bannasch P,Hacker HJ,Mrozek M,Kopp-Schneider A,Elgas M,Roggendorf M.Synergistic hepatocarcinogenic effect of hepadnaviral infection and dietary aflatoxin B1 in woodchucks..Cancer Res1995;55:3318-30

[10] Altmann HW.Hepatic neoformations..Pathol Res Pract1994;190:513-77

[11] Su Q,Hofmann WJ,Pichlmayr R.Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia..Virchows Arch1997;431:391-406

[12] Buchanan TF.Clear-cell carcinoma of the liver. A clinicopathologic study of 13 patients..Am J Clin Pathol1974;61:529-39

[13] Shi Y,Wu W,Yang J.Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis..Liver Int2012;32:231-40

[14] Bannasch P.Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype..World J Gastroenterol2012;18:6701-8 PMCID:PMC3520157

[15] Ribback S,Cigliano A,Peters M,Heidecke CD,Dombrowski F.Molecular and metabolic changes in human clear cell foci resemble the alterations occurring in rat hepatocarcinogenesis..J Hepatol2013;58:1147-56

[16] Teng CF,Wu HC,Tsai HW,Su IJ.Hepatitis B virus pre-S2 mutant induces aerobic glycolysis through mammalian target of rapamycin signal cascade..PLoS One2015;10:e0122373 PMCID:PMC4409318

[17] Bannach P,Mayer D.Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone..J Bioenerg Biomembr1997;29:303-13

[18] Klimek F.Isoenzyme shift from glucokinase to hexokinase is not an early but a late event in hepatocarcinogenesis..Carcinogenesis1993;14:1857-61

[19] Yasuda S,Mori A,Yang W,Fujimoto A,Sakashita H.Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance..J Hepatol2004;40:117-23

[20] Guzman G,Chan A,Quintana A,Xu PZ,Hay N.Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinoma..Dig Dis Sci2015;60:420-6 PMCID:PMC4323170